Empire Genomics is a leader in the field of genomic molecular diagnostics & personalized medicine.
Empire Genomics offers completely integrated products and services focused on providing diagnostic, prognostic, therapeutic and disease-monitoring information for the oncology market. Our flexible and collaborative approach enables personalized medicine by making advanced clinical disease management tools available to oncologists, pathologists and cytogenetic groups. We work with our clients to help make critical healthcare decisions that ultimately improve patient outcomes.
Be the first to know and let us send you an email when Empire Genomics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
